Differential regulation of Th1/Th2 cytokine responses by placental protein 14

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5524-5530

  Mishan Eisenberg, Galit ^a   Borovsky, Zipora ^a   Weber, Matthew C ^b   Gazit, Roi ^c   Tykocinski, Mark L ^b   Rachmilewitz, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 4; PLACENTA PROTEIN 14; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; CELL MATURATION; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 6344274984     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5524     Document Type: Article

References (41)

1. Leitenberg, D., and K. Bottomly. 1999. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin. Immunol. 11:283.
2. Wulfing, C., and M. M. Davis. 1998. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282:2266.
3. Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283:680.
4. Dell, A., H. R. Morris, R. L. Easton, M. Panico, M. Patankar, S. Oehniger, R. Koistinen, H. Koistinen, M. Seppala, and G. F. Clark. 1995. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J. Biol. Chem. 270:24116.
5. Rachmilewitz, J., Z. Borovsky, G. Mishan-Eisenberg, E. Yaniv, G. J. Riely, and M. L. Tykocinski. 2002. Focal localization of placental protein 14 toward sites of TCR engagement. J. Immunol. 168:2745.
6. Rachmilewitz, J., G. J. Riely, J. H. Huang, A. Chen, and M. L. Tykocinski. 2001. A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds. Blood 98:3727.
7. Rachmilewitz, J., Z. Borovsky, G. J. Riely, R. Miller, and M. L. Tykocinski. 2003. Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J. Biol. Chem. 278:14059.
8. Morris, H. R., A. Dell, R. L. Easton, M. Panico, H. Koistinen, R. Koistinen, S. Oehninger, M. S. Patankar, M. Seppala, and G. F. Clark. 1996. Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J. Biol. Chem. 271:32159.
9. Oehninger, S., C. C. Coddington, G. D. Hodgen, and M. Seppala. 1995. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil. Steril. 63:377.
10. Song, M., S. Ramaswamy, S. Ramachandran, L. C. Flowers, I. R. Horowitz, J. A. Rock, and S. Parthasarathy. 2001. Angiogenic role for glycodelin in tumorigenesis. Proc. Natl. Acad. Sci. USA 98:9265.
11. Bohn, H., W. Kraus, and W. Winckler. 1982. New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl 4:67.
12. Julkunen, M., E. M. Rutanen, A. Koskimies, T. Ranta, H. Bohn, and M. Seppala. 1985. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br. J. Obstet. Gynaecol. 92:1145.
13. Kamarainen, M., M. Halttunen, R. Koistinen, K. von Boguslawsky, K. von Smitten, L. C. Andersson, and M. Seppala. 1999. Expression of glycodelin in human breast and breast cancer. Int. J. Cancer 83:738.
14. Horowitz, I. R., C. Cho, M. Song, L. C. Flowers, N. Santanam, S. Parthasarathy, and S. Ramachandran. 2001. Increased glycodelin levels in gynecological malignancies. Int. J. Gynecol. Cancer 11:173.
15. Julkunen, M., T. Wahlstrom, M. Seppala, R. Koistinen, A. Koskimies, U. H. Stenman, and H. Bohn. 1984. Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch. Androl. 12:59.
16. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, and J. L. Strominger. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198:1201.
17. Okamoto, N., A. Uchida, K. Takakura, Y. Kariya, H. Kanzaki, L. Riittinen, R. Koistinen, M. Seppala, and T. Mori. 1991. Suppression by human placental protein 14 of natural killer cell activity. Am. J. Reprod. Immunol. 26:137.
18. Morrow, D. M., N. Xiong, R. R. Getty, M. Z. Ratajczak, D. Morgan, M. Seppala, L. Riittinen, A. M. Gewirtz, and M. L. Tykocinski. 1994. Hematopoietic placental protein 14: an immunosuppressive factor in cells of the megakaryocytic lineage. Am. J. Pathol. 145:1485.
19. Mackenna, A., T. C. Li, C. Dalton, A. Bolton, and I. Cooke. 1993. Placental protein 14 levels in uterine flushing and plasma of women with unexplained infertility. Fertil. Steril. 59:577.
20. Tulppala, M., M. Julkunen, A. Tiitinen, U. H. Stenman, and M. Seppala. 1995. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil. Steril. 63:792.
21. Tomczak, S., V. Briese, S. Kunkel, and H. Muller. 1996. Serum placental protein 14 (PP14) levels in patients with threatened abortion. Arch. Gynecol. Obstet. 258:165.
22. Rachmilewitz, J., G. J. Riely, and M. L. Tykocinski. 1999. Placental protein 14 functions as a direct T-cell inhibitor. Cell. Immunol. 191:26.
23. + subpopulations. Scand. J. Immunol. 43:391.
24. Hamel, M. E., E. E. Eynon, H. F. Savelkoul, A. van Oudenaren, and A. M. Kruisbeek. 1995. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B. Int. Immunol. 7:1065.
25. Nagelkerken, L., K. J. Gollob, M. Tielemans, and R. L. Coffman. 1993. Role of transforming growth factor-β in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B. Eur. J. Immunol. 23:2306.
26. Borovsky, Z., G. Mishan-Eisenberg, E. Yaniv, and J. Rachmilewitz. 2002. Serial triggering of T cell receptors results in incremental accumulation of signaling intermediates. J. Biol. Chem. 277:21529.
27. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
28. Rogers, P. R., and M. Croft. 1999. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J. Immunol. 163:1205.
29. Rogers, P. R., and M. Croft. 2000. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen. J. Immunol. 164:2955.
30. Mackay, C. R. 2001. Chemokines: immunology's high impact factors. Nat. Immunol. 2:95.
31. Murdoch, C., and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032.
32. Jourdan, P., C. Abbal, N. Noraz, T. Hori, T. Uchiyama, J. P. Vendrell, J. Bousquet, N. Taylor, J. Pene, H. Yssel, and N. Nora. 1998. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 160:4153.
33. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597.
34. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
35. Schaeffer, E. M., G. S. Yap, C. M. Lewis, M. J. Czar, D. W. McVicar, A. W. Cheever, A. Sher, and P. L. Schwartzberg. 2001. Mutation of Tec family kinases alters T helper cell differentiation. Nat. Immunol. 2:1183.
36. Lantelme, E., S. Mantovani, B. Palermo, R. Campanelli, F. Sallusto, and C. Giachino. 2001. Kinetics of GATA-3 gene expression in early polarizing and committed human T cells. Immunology 102:123.
37. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
38. Dumont, F. J., M. J. Staruch, P. Fischer, C. DaSilva, and R. Camacho. 1998. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160:2579.
39. Ouyang, W., S. H. Ranganath, K. Weindel, D. Bhattacharya, T. L. Murphy, W. C. Sha, and K. M. Murphy. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745.
40. Ouyang, W., M. Lohning, Z. Gao, M. Assenmacher, S. Ranganath, A. Radbruch, and K. M. Murphy. 2000. State-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12:27.
41. Rachmilewitz, J., and A. Lanzavecchia. 2002. A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol. 23:592.